title: Systematic drug susceptibility testing: a necessary component of the 'DOTS plus' strategy?
authors.forename: P J
authors.initials: PJ
authors.lastname: Grosset
mesh_terms: D000995:Antitubercular Agents / Q000494:pharmacology*; D003140:Communicable Disease Control / Q000592:standards*; D018432:Drug Resistance, Multiple; D006801:Humans; D008826:Microbial Sensitivity Tests; D009169:Mycobacterium tuberculosis / Q000187:drug effects*; D018088:Tuberculosis, Multidrug-Resistant / Q000188:drug therapy
chemical_list: D000995:Antitubercular Agents